In a report published Monday, Jefferies analyst Daniel T. Fannon reiterated a Buy rating on CME Group CME, and raised the price target from $69.00 to $78.00.
In the report, Jefferies noted, “Last week we spent several days with the management team of CME. In addition to record volumes in the core futures business, momentum in OTC clearing is building into the June 10th mandate. While the sustainability of the “rate trade” can be debated, recent trends give a view into the potential for higher volumes in the future.”
CME Group closed on Friday at $67.93.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in